Airteck Pharma Solutions Private Limited
About Airteck Pharma Solutions Private Limited
Data last updated:
Airteck Pharma Solutions Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the metalworking segment of the metals and mining sector. It was incorporated on 09 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U29100AP2019PTC111661. Its GSTIN is 37AASCA1601L1ZJ (Andhra Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Subba Rao Paritala and Haritha Paritala.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at D.No: 31 – 29 – 20/6 Subbaraju Street Kurmannapalem, Visakhapatnam, Andhra Pradesh, India – 530046.
As per the financials filed for FY 2023, the company reported a revenue of ₹5.16 Cr, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹25.97 Lakh (net margin 5%) and EBITDA of ₹52.31 Lakh (EBITDA margin 10.1%). Revenue has grown at a compounded annual rate (CAGR) of 139% over three years.
The company has about 19 employees on its provident fund (EPFO) records.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressD.No: 31 – 29 – 20/6 Subbaraju Street Kurmannapalem, Visakhapatnam, Andhra Pradesh, India – 530046
- IndustryMetal & Minerals, Metalworking
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Airteck Pharma Solutions Private Limited FY 2024 filings available
Airteck Pharma Solutions Private Limited reported revenue of ₹5.16 Cr (down 14% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Airteck Pharma Solutions Private Limited
Revenue fell 14% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 139%. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Airteck Pharma Solutions Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹5.16 Cr | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹52.31 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹25.97 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Airteck Pharma Solutions Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 10.1% | •••• | •••• | •••• |
| Net Profit Margin | 5% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Airteck Pharma Solutions are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Airteck Pharma Solutions Private Limited
Airteck Pharma Solutions Private Limited is audited by VADLAMANI & Co for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VADLAMANI & Co | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Airteck Pharma Solutions Private Limited
Airteck Pharma Solutions has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subba Rao Paritala | Director | 23 Apr 2021 | 5 Years 5 Months | Current |
| Haritha Paritala | Director | 09 Apr 2019 | 7 Years 6 Months | Current |
Ownership and Shareholding of Airteck Pharma Solutions Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Airteck Pharma Solutions Private Limited
Airteck Pharma Solutions Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Airteck Pharma Solutions Private Limited
Airteck Pharma Solutions Private Limited has a workforce of 19 employees as of Apr 05, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Airteck Pharma Solutions Private Limited
Airteck Pharma Solutions Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Suneel Surapuraju ceased to be Director on 04 Oct 2021.
Credit Ratings, Litigation & Regulatory Alerts for Airteck Pharma Solutions Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Airteck Pharma Solutions Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Airteck Pharma Solutions Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Airteck Pharma Solutions Private Limited
Airteck Pharma Solutions has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AASCA1601L1ZJ | Andhra Pradesh | Active | 29 May 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Airteck Pharma Solutions Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Airteck Pharma Solutions Private Limited
Airteck Pharma Solutions is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in metalworking, within the metal and minerals industry. It was incorporated on 09 April 2019 (7+ years old) and is registered under CIN U29100AP2019PTC111661.
Airteck Pharma Solutions reported revenue of ₹5.16 Cr for FY 2023 (down 14% YoY).
Airteck Pharma Solutions has 2 current directors:
- Subba Rao Paritala - Director
- Haritha Paritala - Director
Airteck Pharma Solutions reported a net profit of ₹25.97 Lakh (net margin 5%) and EBITDA of ₹52.31 Lakh (EBITDA margin 10.1%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Airteck Pharma Solutions is 139% over three years. In the latest year (FY 2023) revenue fell 14%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Airteck Pharma Solutions is 37AASCA1601L1ZJ, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Airteck Pharma Solutions is U29100AP2019PTC111661. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Airteck Pharma Solutions was incorporated on 09 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Vijayawada.
Suneel Surapuraju ceased to be Director on 04 Oct 2021. Subba Rao Paritala was appointed as Director on 23 Apr 2021. Raghu Penumatchsa ceased to be Director on 03 Oct 2020. Airteck Pharma Solutions has 4 board changes on record in total.
The registered office of Airteck Pharma Solutions is at D.No: 31 – 29 – 206 Subbaraju Street Kurmannapalem, Visakhapatnam, Andhra Pradesh, India – 530046.